Gilead Sciences' Debt Overview
Portfolio Pulse from Benzinga Insights
Gilead Sciences Inc. (NASDAQ:GILD) has seen its shares decrease by 7.28% over the past three months. The company's total debt stands at $25.24 billion, with long-term debt at $22.96 billion and current debt at $2.28 billion. After adjusting for $4.94 billion in cash-equivalents, the net debt is $20.30 billion. The debt-ratio, a measure of financial leverage, is 0.41, indicating that a significant portion of the company's assets are funded by debt.
June 29, 2023 | 6:02 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Gilead Sciences' shares have decreased by 7.28% over the past three months. The company's total debt is $25.24 billion, with a debt-ratio of 0.41, indicating a significant portion of assets are funded by debt.
The decrease in Gilead Sciences' share price over the past three months could be partially attributed to its high level of debt. The company's debt-ratio of 0.41 indicates that a significant portion of its assets are funded by debt, which could put the company at risk if interest rates were to increase. This could negatively impact the company's short-term stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100